Protein Scaffolds, Antisense Oligonucleotide
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
46
NCT06109948
Study to Assess the Safety, Tolerability, PK and PD of ABX1100
Phase: Early Phase 1
Role: Lead Sponsor
Start: Oct 19, 2023
Completion: Dec 31, 2025
Loading map...